Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Cherubim Interests, Inc. (CHIT) is Well on its Way to Becoming a Leader in Alternative Investment Opportunities

Cherubim Interests (OTC: CHIT), an investment company, focuses its attention on undervalued commercial assets and single and multi-family dwellings for purchase. The company aims to be at the forefront of alternative construction, property management, multifamily real estate, and investment opportunities. The company is involved with each project from beginning to end by covering due diligence, […]

Dataram (DRAM): To Present at Source Capital Group’s 2016 Disruptive Growth and Healthcare Conference

The conference circuit is an all-important part of the growth process for small and start-up companies. Dataram Corp. (NASDAQ: DRAM) announced in a press release that it would be presenting at the Source Capital Group’s 2016 Disruptive Growth and Healthcare Conference in February 2016. This conference will feature executives from life science companies focusing on […]

Legacy Ventures International, Inc. (LGYV) Announces Distribution Agreement with Sysco

Legacy Ventures International, Inc. (OTC: LGYV), through wholly-owned subsidiary RM Fresh Brands, recently entered into a distribution agreement with Sysco (NYSE: SYY), a leading marketer and distributor of food products to restaurants, healthcare and educational facilities, hotels and inns and other foodservice and hospitality businesses. Through this partnership, Legacy will look to expand the distribution […]

International Stem Cell Corp. (ISCO) Gets Regulatory Green Light to Begin Clinical Trial of ISC-hpNSC for the Treatment of Parkinson’s Disease

Currently available Parkinson’s disease treatments, while capable of improving the early symptoms of the disease, lose their effect as the disease progresses and produce involuntary writing movements in the patients. As of yet there is no cure for the disease, which is the second most common neurodegenerative disease and affects over 7 million people worldwide. […]

Nutra Pharma Corp. (NPHC) Engages QualityStocks Corporate Communications Suite

Nutra Pharma Corp., a biopharmaceutical company engaged in the acquisition, licensing and marketing of homeopathic treatments and ethical drugs for the management of pain, neurological disorders, cancer, auto-immune and infectious diseases, today announces that it has engaged the Corporate Communications Services of QualityStocks. Based in Scottsdale, Arizona, QualityStocks has assisted more than 300 public companies […]

 

From Our Blog

Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Announces Final Results from the 2025 Maiden Drilling Program at the West Santa Fe Project, Plans for Spring Drilling Campaign

March 3, 2026

Disseminated on behalf of  Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising. Lahontan Gold (TSX.V: LG) (OTCQB: LGCXF), a mine development and exploration company, recently announced the final analytical results from the company’s 2025 maiden drilling program at the West Santa Fe Project. This project is located only a short distance from […]

Rotate your device 90° to view site.